Suchergebnisse - "Sunil, Venkategowda"

PubPharm (14)

1

Effect of hesperidin on blood pressure and lipid profile : A systematic review and meta-analysis of randomized controlled trials

enthalten in: Phytotherapy research : PTR | 2024

von Shylaja, H. | Viswanatha, G. | Sunil, V. | +2

2

Response surface methodology based development of an optimized polyherbal formulation and evaluation of its anti-diabetic and anti-obesity potential in high-fat diet-induced obese mice

in: Journal of Traditional and Complementary Medicine | 2024

von Tanisha | Sunil Venkategowda | Mala Majumdar

3

CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models

enthalten in: Diabetology & metabolic syndrome | 2014

von Sadasivuni, M. | Reddy, B. | Singh, J. | +17

4

CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models

enthalten in: Diabetology & metabolic syndrome | 2014

von Sadasivuni, M. | Reddy, B. | Singh, J. | +17

5

A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits

enthalten in: BMC pharmacology & toxicology | 2014

von Anil, T. | Dandu, A. | Harsha, K. | +16

6

A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits

enthalten in: BMC pharmacology & toxicology | 2014

von Anil, T. | Dandu, A. | Harsha, K. | +16

7

A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits

enthalten in: BMC pharmacology & toxicology | 2014

von Anil, T. | Dandu, A. | Harsha, K. | +16

8

CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients

enthalten in: BMC pharmacology & toxicology | 2014

von Sunil, V. | Verma, M. | Oommen, A. | +11

9

CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients

enthalten in: BMC pharmacology & toxicology | 2014

von Sunil, V. | Verma, M. | Oommen, A. | +11

10

CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients

enthalten in: BMC pharmacology & toxicology | 2014

von Sunil, V. | Verma, M. | Oommen, A. | +11